39277808|t|Evaluation of the effect of taurine on the matrix metalloproteinase-9 and the expression changes of miRNA-21 and miRNA-146a in SH-SY5Y cell line.
39277808|a|OBJECTIVES: Alzheimer's disease (AD), a brain disorder, is the leading cause of dementia among older adults. Taurine, an amino acid abundantly present in the brain, and shows potential neuroprotective properties. Therefore, we investigated the effects of taurine on Matrix Metalloproteinase-9 (MMP-9) levels and the expression changes of miRNA-21 and miRNA-146a in the SH-SY5Y cell line. METHODS: Taurine's impact on the SH-SY5Y cell line was evaluated via the 2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. MMP-9 levels were measured using an enzyme-linked immunosorbent assay (ELISA) kit, while the expression of miRNA-21 and miRNA-146a genes was assessed through Real-Time PCR analysis. RESULTS: The MTT assay revealed no toxic effects on SH-SY5Y cells with increasing concentrations of taurine. Analysis of gene expression indicated a rise in miRNA-21 expression and a decline in miRNA-146 expression with increasing taurine concentration, with the most notable change observed at 1 mg/mL taurine (p<0.001). ELISA results demonstrated a significant increase in MMP-9 levels in the SH-SY5Y cell line treated with 1 mg/mL taurine compared to the untreated group (p<0.001). CONCLUSIONS: Our study revealed that taurine can alter the expression of miRNA-146a and miRNA-21. In conclusion, taurine therapy presents promising therapeutic avenues for treating AD or mitigating severe symptoms. Nonetheless, further research is necessary to comprehensively grasp the precise mechanisms at play.
39277808	28	35	taurine	Chemical	MESH:D013654
39277808	43	69	matrix metalloproteinase-9	Gene	4318
39277808	100	108	miRNA-21	Gene	406991
39277808	113	123	miRNA-146a	Gene	406938
39277808	127	134	SH-SY5Y	CellLine	CVCL:0019
39277808	158	177	Alzheimer's disease	Disease	MESH:D000544
39277808	179	181	AD	Disease	MESH:D000544
39277808	186	200	brain disorder	Disease	MESH:D001927
39277808	226	234	dementia	Disease	MESH:D003704
39277808	255	262	Taurine	Chemical	MESH:D013654
39277808	267	277	amino acid	Chemical	MESH:D000596
39277808	401	408	taurine	Chemical	MESH:D013654
39277808	412	438	Matrix Metalloproteinase-9	Gene	4318
39277808	440	445	MMP-9	Gene	4318
39277808	484	492	miRNA-21	Gene	406991
39277808	497	507	miRNA-146a	Gene	406938
39277808	515	522	SH-SY5Y	CellLine	CVCL:0019
39277808	543	550	Taurine	Chemical	MESH:D013654
39277808	567	574	SH-SY5Y	CellLine	CVCL:0019
39277808	607	642	2,5-diphenyl-2H-tetrazolium bromide	Chemical	-
39277808	644	647	MTT	Chemical	MESH:C070243
39277808	656	661	MMP-9	Gene	4318
39277808	763	771	miRNA-21	Gene	406991
39277808	776	786	miRNA-146a	Gene	406938
39277808	851	854	MTT	Chemical	MESH:C070243
39277808	890	897	SH-SY5Y	CellLine	CVCL:0019
39277808	938	945	taurine	Chemical	MESH:D013654
39277808	995	1003	miRNA-21	Gene	406991
39277808	1069	1076	taurine	Chemical	MESH:D013654
39277808	1141	1148	taurine	Chemical	MESH:D013654
39277808	1213	1218	MMP-9	Gene	4318
39277808	1233	1240	SH-SY5Y	CellLine	CVCL:0019
39277808	1272	1279	taurine	Chemical	MESH:D013654
39277808	1360	1367	taurine	Chemical	MESH:D013654
39277808	1396	1406	miRNA-146a	Gene	406938
39277808	1411	1419	miRNA-21	Gene	406991
39277808	1436	1443	taurine	Chemical	MESH:D013654
39277808	1504	1506	AD	Disease	MESH:D000544
39277808	Association	MESH:D013654	406938
39277808	Negative_Correlation	MESH:D013654	MESH:D000544
39277808	Positive_Correlation	MESH:D013654	4318
39277808	Association	MESH:D013654	406991

